These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 18831408)

  • 41. Extraesophageal manifestations of gastroesophageal reflux disease: real or imagined?
    Moore JM; Vaezi MF
    Curr Opin Gastroenterol; 2010 Jul; 26(4):389-94. PubMed ID: 20473157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Con: Impedance-pH testing does not commonly alter management of GERD.
    Richter JE
    Am J Gastroenterol; 2009 Nov; 104(11):2667-9. PubMed ID: 19888231
    [No Abstract]   [Full Text] [Related]  

  • 43. Esophageal impedance monitoring and pathophysiology of gastroesophageal reflux disease.
    Sifrim D
    Verh K Acad Geneeskd Belg; 2006; 68(3):151-78. PubMed ID: 16796016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors.
    Sifrim D; Zerbib F
    Gut; 2012 Sep; 61(9):1340-54. PubMed ID: 22684483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Catheter-based pH monitoring: use in evaluation of gastroesophageal reflux disease symptoms (on and off therapy).
    DeVault KR
    Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):289-306. PubMed ID: 15722242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reflux monitoring.
    Stein E; Katz PO
    Rev Gastroenterol Disord; 2009; 9(2):E54-62. PubMed ID: 19668126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of heartburn not responding to proton pump inhibitors.
    Fass R; Sifrim D
    Gut; 2009 Feb; 58(2):295-309. PubMed ID: 19136523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
    Ghoshal UC; Chourasia D; Tripathi S; Misra A; Singh K
    Scand J Gastroenterol; 2008; 43(6):654-61. PubMed ID: 18569981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evolving issues in the management of reflux disease?
    Yuan Y; Hunt RH
    Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Addition of pH-impedance monitoring to standard pH monitoring increases the yield of symptom association analysis in infants and children with gastroesophageal reflux.
    Loots CM; Benninga MA; Davidson GP; Omari TI
    J Pediatr; 2009 Feb; 154(2):248-52. PubMed ID: 18823910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-acid reflux: detection by multichannel intraluminal impedance and pH, clinical significance and management.
    Vela MF
    Am J Gastroenterol; 2009 Feb; 104(2):277-80. PubMed ID: 19190606
    [No Abstract]   [Full Text] [Related]  

  • 53. Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review.
    Zentilin P; Dulbecco P; Savarino E; Giannini E; Savarino V
    Dig Liver Dis; 2004 Sep; 36(9):565-9. PubMed ID: 15460839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Esophageal impedance baselines in infants before and after placebo and proton pump inhibitor therapy.
    Loots CM; Wijnakker R; van Wijk MP; Davidson G; Benninga MA; Omari TI
    Neurogastroenterol Motil; 2012 Aug; 24(8):758-62, e351-2. PubMed ID: 22512786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Precise role of acid in non-erosive reflux disease.
    Wang C; Hunt RH
    Digestion; 2008; 78 Suppl 1():31-41. PubMed ID: 18832838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux.
    Hila A; Agrawal A; Castell DO
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):172-7. PubMed ID: 17296528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relevance of reflux monitoring off therapy.
    Savarino E; Zentilin P; Savarino V
    Am J Gastroenterol; 2011 Aug; 106(8):1558-9; author reply 1559. PubMed ID: 21811280
    [No Abstract]   [Full Text] [Related]  

  • 58. Indications, methodology, and interpretation of combined esophageal impedance-pH monitoring in children: ESPGHAN EURO-PIG standard protocol.
    Wenzl TG; Benninga MA; Loots CM; Salvatore S; Vandenplas Y;
    J Pediatr Gastroenterol Nutr; 2012 Aug; 55(2):230-4. PubMed ID: 22711055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ambulatory 24-h oesophageal impedance-pH recordings: reliability of automatic analysis for gastro-oesophageal reflux assessment.
    Roman S; Bruley des Varannes S; Pouderoux P; Chaput U; Mion F; Galmiche JP; Zerbib F;
    Neurogastroenterol Motil; 2006 Nov; 18(11):978-86. PubMed ID: 17040408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extra-esophageal manifestations of gastroesophageal reflux.
    Farrokhi F; Vaezi MF
    Oral Dis; 2007 Jul; 13(4):349-59. PubMed ID: 17577320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.